Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

High tumoral maspin expression is associated with improved survival of patients with oral squamous cell carcinoma

Abstract

Maspin, a member of the serpin family of protease inhibitors, is known to have tumor-suppressor functions. However, the association between its expression level and survival has not been demonstrated in human cancer. Using the immunohistochemical technique to examine the expression levels of maspin in 44 cases of oral squamous cell carcinoma (SCC), we found that 66% of the cases expressed low to intermediate levels of maspin and 34% of the cases expressed high levels of maspin. We further examined maspin protein expression in a series of six SCC cell lines from the head and neck, and found that all but one expressed low or no maspin protein. We also compared the clinicopathological features of the oral SCC cases with the maspin expression level, and found that high maspin expression was associated with the absence of lymph node metastasis. More importantly, we showed that higher maspin expression was significantly associated with better rates of overall survival, suggesting that high maspin expression may be a favorable prognostic marker for oral SCC.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Ahomadegbe JC, Barrois M, Fogel S, Le Bihan ML, Douc-Rasy S, Duvillard P, Armand JP and Riou G . 1995 Oncogene 10: 1217–1227

  • Berenson JR, Yang J and Mickel RA . 1989 Oncogene 4: 1111–1116

  • Field JK, Spandidos DA, Stell PM, Vaughan ED, Evan GI and Moore JP . 1989 Oncogene 4: 1463–1468

  • Pemberton PA, Tipton AR, Pavloff N, Smith J, Erickson JR, Mouchabeck ZM and Kiefer MC . 1997 J Histochem Cytochem 45: 1697–1706

  • Sager R, Sheng S, Pemberton P and Hendrix MJ . 1996 Curr Topics Microbiol Immunol 213: 51–64

  • Sheng S, Carey J, Seftor EA, Dias L, Hendrix MJ and Sager R . 1996 Proc Natl Acad Sci USA 93: 11669–11674

  • Sheng S, Pemberton PA and Sager R . 1994 J Biol Chem 269: 30988–30993

  • Sheng S, Truong B, Fredrickson D, Wu R, Pardee AB and Sager R . 1998 Proc Natl Acad Sci USA 95: 499–504

  • Somers KD, Merrick MA, Lopez ME, Incognito LS, Schechter GL and Casey G . 1992 Cancer Res 52: 5997–6000

  • Sternlicht MD, Kedeshian P, Shao ZM, Safarians S and Barsky SH . 1997 Clin Cancer Res 3: 1949–1958

  • Umekita Y, Hiipakka RA and Liao S . 1997 Cancer Lett 113: 87–93

  • Watling DL, Gown AM and Coltrera MD . 1992 Head & Neck 14: 437–444

  • Xia W, Lau Y-K, Zhang H-Z, Liu A-R, Kiyokawa N, Clayman GL, Katz RL and Hung M-C . 1997 Clin Cancer Res 3: 3–9

  • Yamamoto T, Kamata N, Kawano H, Shimizu S, Kuroki T, Toyoshima K, Rikimaru K, Nomura N, Ishizaki R, Pastan I, Gamou S and Shimizu N . 1986 Cancer Res 46: 414–416

  • Zhang M, Maass N, Magit D and Sager R . 1997a Cell Growth Differ 8: 179–186

  • Zhang M, Magit D and Sager R . 1997b Proc Natl Acad Sci USA 94: 5673–5678

  • Zou Z, Anisowicz A, Hendrix MJ, Thor A, Neveu M, Sheng S, Rafidi K, Seftor E and Sager R . 1994 Science 263: 526–529

Download references

Acknowledgements

We thank Dr Douglas Boyd for generously providing the human keratinocyte cell line. This study was supported in part by MD Anderson Faculty Achievement Award (to M-C Hung), and MD Anderson Nellie Connally Breast Cancer Research Fund (to M-C Hung).

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Xia, W., Lau, YK., Hu, MT. et al. High tumoral maspin expression is associated with improved survival of patients with oral squamous cell carcinoma. Oncogene 19, 2398–2403 (2000). https://doi.org/10.1038/sj.onc.1203535

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1203535

Keywords

This article is cited by

Search

Quick links